ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Initiating Early Control of Migraine Pain and Associated Symptoms

ClinicalTrials.gov ID: NCT04163185

Public ClinicalTrials.gov record NCT04163185. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 2:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Single-dose, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-07 (Meloxicam and Rizatriptan) for the Acute Treatment of Migraine in Adults

Study identification

NCT ID
NCT04163185
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Axsome Therapeutics, Inc.
Industry
Enrollment
302 participants

Conditions and interventions

Conditions

Interventions

  • AXS-07 (MoSEIC meloxicam and rizatriptan) Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 7, 2019
Primary completion
Mar 15, 2020
Completion
Mar 22, 2020
Last update posted
Jan 27, 2026

2019 – 2020

United States locations

U.S. sites
41
U.S. states
19
U.S. cities
40
Facility City State ZIP Site status
Clinical Research Site Birmingham Alabama 35205
Clinical Research Site Birmingham Alabama 35216
Clinical Research Site Mobile Alabama 36608
Clinical Research Site Colton California 92399
Clinical Research Site Encino California 91316
Clinical Research Site Los Alamitos California 90720
Clinical Research Site Los Angeles California 90017
Clinical Research Site Redlands California 92374
Clinical Research Site Santa Monica California 90404
Clinical Research Site Spring Valley California 91978
Clinical Research Site Walnut Creek California 94598
Clinical Research Site Hallandale Florida 33009
Clinical Research Site Jacksonville Florida 32256
Clinical Research Site Lake City Florida 32055
Clinical Research Site Lake Worth Florida 33467
Clinical Research Site Ocoee Florida 34761
Clinical Research Site Orlando Florida 32801
Clinical Research Site Ormond Beach Florida 32174
Clinical Research Site South Miami Florida 33143
Clinical Research Site Sunrise Florida 33351
Clinical Research Site Tampa Florida 33634
Clinical Research Site Stockbridge Georgia 30281
Clinical Research Site Evanston Illinois 60201
Clinical Research Site Louisville Kentucky 40213
Clinical Research Site Boston Massachusetts 02131
Clinical Research Site Waltham Massachusetts 02451
Clinical Research Site Ann Arbor Michigan 48104
Clinical Research Site Springfield Missouri 65810
Clinical Research Site Albuquerque New Mexico 87102
Clinical Research Site Manlius New York 13104
Clinical Research Site Williamsville New York 14221
Clinical Research Site High Point North Carolina 27262
Clinical Research Site Oklahoma City Oklahoma 73106
Clinical Research Site Philadelphia Pennsylvania 19114
Clinical Research Site Charleston South Carolina 29406
Clinical Research Site Mt. Pleasant South Carolina 29464
Clinical Research Site Memphis Tennessee 38119
Clinical Research Site Nashville Tennessee 37203
Clinical Research Site Austin Texas 78731
Clinical Research Site Salt Lake City Utah 84107
Clinical Research Site Charlottesville Virginia 22911

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04163185, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 27, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04163185 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →